Three-Statement Breakdown
REVENUE UP
Revenue rose 5.9% year over year to $42.9B, and carried a 10.5% net margin.
REVENUE
+5.9%
42,892
GROSS PROFIT
—
—
NET INCOME
+14.0%
4,496
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40,985 | 41,033 | 40,368 | 40,501 | 40,928 | 41,954 | 42,367 | 42,892 | +1.2% | +5.9% | |
| SG&A | (4,027) | (3,992) | (3,937) | (3,852) | (3,851) | (4,033) | (3,997) | (4,006) | +0.2% | +4.0% | |
| Operating income | 2,888 | 4,370 | 3,872 | 4,207 | 4,329 | 4,511 | 4,927 | 4,598 | -6.7% | +9.3% | |
| Interest expense | (589) | (621) | (631) | (650) | (650) | (665) | (671) | (659) | -1.8% | +1.4% | |
| Income tax | (333) | (842) | (752) | (799) | (860) | (886) | (944) | (765) | -19.0% | -4.3% | |
| Net income | 2,375 | 4,174 | 3,711 | 3,945 | 4,019 | 4,182 | 4,576 | 4,496 | -1.7% | +14.0% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-21 ↗